Merck Sues To Block Generic Singulair

Law360, New York (April 10, 2007, 12:00 AM EDT) -- Hoping to take the air out of Teva Pharmaceuticals USA’s plans for a generic version of its most popular drug, Merck & Co. Inc. has filed a patent lawsuit to keep a competing version of popular asthma and allergy drug Singulair from hitting the market.

Merck claimed that Teva Pharmaceuticals USA’s Abbreviated New Drug Application with the U.S. Food and Drug Administration for a generic Singulair violates a Merck patent.

In the lawsuit filed under Merck's Barbados-based affiliate, Merck Sharp & Dohme Pharmaceuticals SRL, the drug...
To view the full article, register now.